EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection

Edward E Walsh iD, Michael Peasley, Angela R Branche iD, Ann R Falsey

The Journal of Infectious Diseases · 11.07.2025 · 231 (6) · e1146-e1150

DOI: 10.1093/infdis/jiaf149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 24.03.2025. Verfasst von Edward E Walsh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Antibodies, Viral, Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunity to respiratory syncytial virus (RSV) is short lived following infection. We determined if recently licensed RSV preF vaccines induce better immune responses than infection.

Methods

Serum preF binding and neutralizing antibody to RSV A and B was measured in older adults at baseline and 30 days after RSV infection or vaccination with 2 licensed RSV preF protein vaccines.

Results

Vaccination induced higher serum preF binding antibody and neutralizing responses than RSV infection (A2 RSV, 3306 vs 1254, P < .0001; B1 RSV, 5153 vs 2186, P < .0001).

Conclusions

Vaccination with preF protein vaccines induce better humoral immune responses than RSV infection in older adult.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsAntibodies, ViralRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanImmunity, HumoralHumansAgedMaleFemaleAntibodies, NeutralizingAged, 80 and overVaccinationMiddle Aged

Stichwörter der Autor:innen

RSV infectionRSV preF vaccinesadultshumoral antibody response

Substanzen

Antibodies, ViralRespiratory Syncytial Virus VaccinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

ORCID-Profile: Edward E Walsh, Angela R Branche

Zitieren

APA

Walsh, E. E., Peasley, M., Branche, A. R., & Falsey, A. R. (2025). Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection. The Journal of Infectious Diseases, 231(6), e1146-e1150. https://doi.org/10.1093/infdis/jiaf149

Vancouver

Walsh EE, Peasley M, Branche AR, Falsey AR. Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection. The Journal of Infectious Diseases. 2025;231(6):e1146-e1150. doi:10.1093/infdis/jiaf149

BibTeX
@article{Walsh2025,
  author = {Walsh, Edward E and Peasley, Michael and Branche, Angela R and Falsey, Ann R},
  title = {Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {6},
  pages = {e1146--e1150},
  doi = {10.1093/infdis/jiaf149}
}
Kostenlos starten →